Related Experiment Video
Updated: Jun 13, 2026

09:33
Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
Published on: July 28, 2013
Diffusion tensor imaging (DTI) in dementia patients with frontal lobe symptoms
Mala Naik1, Arvid Lundervold, Harald Nygaard
1Departments of Geriatrics and Radiology, Haraldsplass Deaconess Hospital, University of Bergen, Ulriksdal 8, Bergen, Norway. mnaik@broadpark.no
Acta Radiologica (Stockholm, Sweden : 1987)
|May 1, 2010
Summary
This study found that reduced fractional anisotropy (FA) in the frontal lobes is linked to frontal lobe symptoms in dementia patients. Lower FA indicates white matter changes associated with cognitive decline.
Area of Science:
- Neuroimaging
- Neurology
- Medical Research
Background:
- Diffusion Tensor Imaging (DTI) visualizes brain white matter tracts.
- DTI detects axonal fiber loss and myelin reduction in dementia.
- Dementia is a neurodegenerative disease impacting cognitive function.
Purpose of the Study:
- To investigate the correlation between frontal lobe symptoms in dementia patients and fractional anisotropy (FA) in frontal white matter.
- To assess if reduced FA in frontal white matter is associated with specific dementia symptoms.
Main Methods:
- Included 23 dementia patients with frontal lobe symptoms and 20 controls (Alzheimer's patients without frontal symptoms and healthy controls).
- Utilized clinical assessments of frontal lobe function and Diffusion Tensor Imaging (DTI) MRI.
- Analyzed FA in subcortical frontal white matter and correlated it with clinical frontal lobe scores.
Main Results:
- A significant correlation was observed between frontal lobe symptom scores and reduced FA in the frontal lobes.
- Patients with dementia and frontal lobe symptoms exhibited significantly lower FA compared to control groups.
Conclusions:
- The study suggests a probable correlation between the severity of frontal lobe symptoms and FA levels in frontal white matter.
- Reduced FA in frontal white matter may serve as a biomarker for frontal lobe dysfunction in dementia.

